| 1 |
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly |
|
|
| Annamaria Colao,Renata S. Auriemma,Rosario Pivonello,Leandro Kasuki,Mônica R. Gadelha |
|
| Pituitary. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Treatment of acromegaly in the era of personalized and predictive medicine |
|
|
| Manuel Puig Domingo |
|
| Clinical Endocrinology. 2015; 83(1): 3 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Diagnosis, treatment and clinical perspectives of acromegaly |
|
|
| Ferdinand Roelfsema,Gerrit van den Berg |
|
| Expert Review of Endocrinology & Metabolism. 2015; 10(6): 619 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide |
|
|
| Baldomero Gonzalez,Guadalupe Vargas,Claudia Ramirez,Silvia Asa,Sonia Cheng,Carolina Sandoval,Moises Mercado |
|
| Endocrinología y Nutrición (English Edition). 2014; 61(10): 523 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide |
|
|
| Baldomero Gonzalez,Guadalupe Vargas,Claudia Ramirez,Silvia Asa,Sonia Cheng,Carolina Sandoval,Moises Mercado |
|
| Endocrinología y Nutrición. 2014; 61(10): 523 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases |
|
|
| Burton, T. and Le Nestour, E. and Bancroft, T. and Neary, M. |
|
| Pituitary. 2013; 16(3): 354-362 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases |
|
|
| Tanya Burton,Elisabeth Nestour,Tim Bancroft,Maureen Neary |
|
| Pituitary. 2013; 16(3): 354 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases |
|
|
| M. Wang,C. Mou,M. Jiang,L. Han,S. Fan,C. Huan,X. Qu,T. Han,Y. Qu,G. Xu |
|
| European Journal of Endocrinology. 2012; 166(5): 797 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: Clinical analysis of 279 cases |
|
|
| Wang, M. and Mou, C. and Jiang, M. and Han, L. and Fan, S. and Huan, C. and Qu, X. and Han, T. and Qu, Y. and Xu, G. |
|
| European Journal of Endocrinology. 2012; 166(5): 797-802 |
|
| [Pubmed] [Google Scholar] |
|
